Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

PSMA-targeted18F-labeled Radiohybrid Inhibitors: Concept, preclinical evaluation and first proof of concept study in men

Alexander Wurzer, Daniel Di Carlo, Alexander Schmidt, Roswitha Beck, Matthias Eiber, Markus Schwaiger and Hans Wester
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 344;
Alexander Wurzer
3Pharmaceutical Radiochemistry Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Di Carlo
3Pharmaceutical Radiochemistry Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Schmidt
3Pharmaceutical Radiochemistry Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roswitha Beck
3Pharmaceutical Radiochemistry Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
1Klinikum rechts der Isar Munich Germany
2Klinikum rechts der Isar Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
1Klinikum rechts der Isar Munich Germany
2Klinikum rechts der Isar Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Wester
3Pharmaceutical Radiochemistry Technical University Munich Garching Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 60 no. supplement 1 344

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 21, 2019.

Copyright & Usage 
© 2019

Author Information

  1. Alexander Wurzer3,
  2. Daniel Di Carlo3,
  3. Alexander Schmidt3,
  4. Roswitha Beck3,
  5. Matthias Eiber1,2,
  6. Markus Schwaiger1,2 and
  7. Hans Wester3
  1. 1Klinikum rechts der Isar Munich Germany
  2. 2Klinikum rechts der Isar Munich Germany
  3. 3Pharmaceutical Radiochemistry Technical University Munich Garching Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2019 to April 2025

AbstractFullPdf
May 2019900
Jun 201913200
Jul 201914300
Aug 20192800
Sep 20192800
Oct 20192900
Nov 201922800
Dec 20195000
Jan 20204100
Feb 20201800
Mar 20203700
Apr 20201700
May 2020800
Jun 20201300
Jul 20201400
Aug 20202600
Sep 20203300
Oct 20202600
Nov 20202900
Dec 20206100
Jan 2021700
Feb 20211400
Mar 20211700
Apr 20211800
May 20213800
Jun 20211800
Jul 20212800
Aug 20214000
Sep 20212300
Oct 20212400
Nov 20218000
Dec 20215700
Jan 20228800
Feb 20222300
Mar 20222200
Apr 2022800
May 20222900
Jun 20221300
Jul 2022300
Aug 2022800
Sep 20221700
Oct 2022800
Nov 2022800
Dec 20221000
Jan 2023700
Feb 20231200
Mar 2023600
Apr 20231900
May 2023400
Jun 2023600
Jul 2023500
Aug 2023400
Sep 20231000
Oct 2023400
Nov 2023900
Dec 2023500
Jan 20241200
Feb 20242100
Mar 20241200
Apr 2024400
May 2024900
Jun 20241000
Jul 2024900
Aug 20241300
Sep 20241100
Oct 2024200
Nov 2024600
Dec 2024500
Jan 2025400
Feb 2025500
Mar 2025200
Apr 20251000
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PSMA-targeted18F-labeled Radiohybrid Inhibitors: Concept, preclinical evaluation and first proof of concept study in men
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
PSMA-targeted18F-labeled Radiohybrid Inhibitors: Concept, preclinical evaluation and first proof of concept study in men
Alexander Wurzer, Daniel Di Carlo, Alexander Schmidt, Roswitha Beck, Matthias Eiber, Markus Schwaiger, Hans Wester
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 344;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
PSMA-targeted18F-labeled Radiohybrid Inhibitors: Concept, preclinical evaluation and first proof of concept study in men
Alexander Wurzer, Daniel Di Carlo, Alexander Schmidt, Roswitha Beck, Matthias Eiber, Markus Schwaiger, Hans Wester
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 344;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
  • A Unique 18F-labeled G-protein-coupled receptor 44 (GPR44) radiotracer: design, radio-synthesis and evaluation in the rodents
  • 18F-Radiofluorination of Aryl C-H Bonds using a Tandem Ir C-H Borylation/Cu Radiofluorination Strategy
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Novel Radiochemistry for Cancer Applications

  • First-in-human study of a novel somatostatin receptor antagonist 68Ga-NODAGA-LM3 for molecular imaging of paraganglioma patients
  • Yttrium-86 PET imaging in rodents to better understand the biodistribution and clearance of gadolinium-based contrast agents used in MRI.
  • Comparison of [18F]DCFPyL Analogues Targeting Prostate-Specific Membrane Antigen (PSMA) in Human Prostate Cancer Xenograft (PCaX) Mouse Models
Show more Novel Radiochemistry for Cancer Applications

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire